TW-37
Cat. No.:YN270139
产品名称: | TW-37 |
CAS No.: | 877877-35-5 |
Chemical Name: | N-[4-[[2-(1,1-dimethylethyl)phenyl]sulfonyl]phenyl]-2,3,4-trihydroxy-5-[[2-(1-methylethyl)phenyl]methyl]-benzamide |
Synonyms: | TW 37 |
分子量: | 573.70 |
分子式: | C₃₃H₃₅NO₆S |
SMILES: | O=C(C1=CC(CC2=CC=CC=C2C(C)C)=C(C(O)=C1O)O)NC3=CC=C(C=C3)S(=O)(C4=CC=CC=C4C(C)(C)C)=O |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | TW-37 是一种有效的Bcl-2抑制剂,作用于Mcl-1,Bcl-2和Bcl-xL,Ki值分别为 260,290 和 1110 nM。 |
IC50和靶点: | [{name:"Mcl-1:260 nM (Ki)"},{name: "Bcl-2:290 nM (Ki)"},{name: "Bcl-xL:1110 nM (Ki)"}] |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Verhaegen, M., Bauer, J.A., de la Vega, C.M., et al.A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen speciesCancer Res.66(23),11348-11359(2006)
Zeitlin, B.D., Joo, E., Dong, Z., et al.Antiangiogenic effect of TW37, a small-molecule inhibitor of Bcl-2Cancer Res.66(17),8698-8706(2006)
Azmi, A.S., and Mohammad, R.M.Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapyJ. Cell Physiol.218(1),13-21(2009)